HPV infection after cervical cancer treatment study
Part of Cancer, Infections, Women’s health & pregnancy clinical trials.
This study looks at whether HPV infection stays in the body during and after standard radiation treatment for cervical cancer, and if that affects how well the treatment works. It aims to understand more about why some people respond better than others.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a common type of cervical cancer linked to HPV (squamous cell, adenocarcinoma, or adenosquamous).
- You have not yet had any cancer treatment (no surgery, chemo, or radiation).
- Your cancer is stage IB3 to IVA, meaning it has spread within the pelvis but not to distant organs.
- You are scheduled to receive radiation therapy to the pelvis, often with chemotherapy, as your main treatment.
- You are not pregnant, not in the postpartum period, and do not have a condition that weakens the immune system (like active HIV, autoimmune disease, or a transplant).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial checks if HPV is still present after standard radiation and chemo for cervical cancer. It may help see how well the treatment worked.
This Phase 3 study tests whether giving additional (adjuvant) chemotherapy after standard chemoradiation can help people whose blood test still shows cancer-related HPV DNA. It may help by lowering the risk of the cervical cancer coming back in people who have a positive blood biomarker after treatment.
This trial studies a blood test that looks for HPV DNA after cervical cancer surgery. The test may help doctors predict if the cancer might come back and decide if more treatment is needed.
This trial checks how well cervical cancer responds to surgery, radiation, and chemotherapy by measuring HPV DNA and RNA in blood and cervical mucus. It aims to improve monitoring during treatment.
This Phase 3 trial studies how best to treat intermediate-risk cervical cancer using radical surgery, with or without additional radiation after surgery. It may help find which approach lowers the chance the cancer comes back for patients with certain tumor risk features.
This trial aims to develop a vaccine that trains your immune system to fight HPV, the virus that causes cervical cancer. By studying your blood, researchers hope to find better ways to prevent the cancer from coming back.
Hear when a new Locally Advanced Cervical Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.